These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 14640057

  • 1. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB, Hulscher JB, Steller EP, van Lanschot JJ, Richel DJ.
    Ned Tijdschr Geneeskd; 2003 Nov 08; 147(45):2207-12. PubMed ID: 14640057
    [Abstract] [Full Text] [Related]

  • 2. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
    Gupta RA, Dubois RN.
    Nat Rev Cancer; 2001 Oct 08; 1(1):11-21. PubMed ID: 11900248
    [Abstract] [Full Text] [Related]

  • 3. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM, Lindley C.
    Ann Pharmacother; 2003 Nov 08; 37(11):1664-74. PubMed ID: 14565811
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR, DuBois RN.
    J Clin Oncol; 2005 Apr 20; 23(12):2840-55. PubMed ID: 15837998
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A, Fernandez PM, Chughtai OR, Kaiser HE.
    In Vivo; 2002 Apr 20; 16(6):501-9. PubMed ID: 12494894
    [Abstract] [Full Text] [Related]

  • 10. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA.
    Semin Urol Oncol; 2001 Nov 20; 19(4):306-16. PubMed ID: 11769882
    [Abstract] [Full Text] [Related]

  • 11. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
    Florent C, Meary N.
    Bull Cancer; 2004 May 20; 91 Spec No():S85-8. PubMed ID: 15239335
    [Abstract] [Full Text] [Related]

  • 12. Colorectal cancer and non-steroidal anti-inflammatory drugs.
    Ota S, Bamba H, Kato A.
    Acta Pharmacol Sin; 2000 May 20; 21(5):391-5. PubMed ID: 11324434
    [Abstract] [Full Text] [Related]

  • 13. The prevention of colorectal cancer by aspirin use.
    Giovannucci E.
    Biomed Pharmacother; 1999 Aug 20; 53(7):303-8. PubMed ID: 10472428
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. COX-2 inhibition and prevention of cancer.
    Giercksky KE.
    Best Pract Res Clin Gastroenterol; 2001 Oct 20; 15(5):821-33. PubMed ID: 11566043
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
    Sanborn R, Blanke CD.
    Semin Oncol; 2005 Feb 20; 32(1):69-75. PubMed ID: 15726508
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans JF, Gallinger S.
    Cancer Res; 2001 Aug 15; 61(16):6131-6. PubMed ID: 11507063
    [Abstract] [Full Text] [Related]

  • 19. Cyclo-oxygenase 2 inhibitors: emerging roles in the gut.
    Grover JK, Yadav S, Vats V, Joshi YK.
    Int J Colorectal Dis; 2003 Jul 15; 18(4):279-91. PubMed ID: 12774242
    [Abstract] [Full Text] [Related]

  • 20. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
    Strul H, Arber N.
    Isr Med Assoc J; 2000 Sep 15; 2(9):695-702. PubMed ID: 11062772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.